Fenoldopam in critically ill patients with early renal dysfunction. A crossover study

Cardiovascular Therapeutics

Volumn 29, Issue 4, 2011, Pages 280-284

  Cobas, Miguel ^a   Paparcuri, Gian ^a   de la Pena, Maria ^a   Cudemus, Gaston ^a   Barquist, Erik ^a   Varon, Albert ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Critical care; Medicine; Pharmacology; Renal dysfunction

Indexed keywords

CREATININE; FENOLDOPAM; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ACUTE KIDNEY INJURY; ADULT; AGED; CRITICAL ILLNESS; CROSS-OVER STUDIES; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; FENOLDOPAM; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 79960268279     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2010.00217.x     Document Type: Article

References (19)

1. Triverio PA, Martin PY, Romand J, Pugin J, Perneger T, Saudan P. Long-term prognosis after acute kidney injury requiring renal replacement therapy. Nephrol Dial Transplant 2009;24:2186-2189.
2. Levy EM. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-1494.
3. Salahudeen AK. "Fenoldopam Prophylaxis" works in impending acute renal failure: Recruiting the non-hemodynamic properties of fenoldopam? The Internet Journal of Emergency and Intensive Care Medicine™ ISSN: 1092-4051. Available from: [Accessed 24 June 2009.
4. Turney JH. Acute renal failure: A dangerous condition. JAMA 1996;275:1516-1517.
5. Cogliati AA, Vellutini R, Nardini A, Uvori S, Hamdan M, Landoni G, Guelfi P. Fenoldopam infusion for renal protection in high risk cardiac surgery: A randomized clinical study. J Cardiothorac Vasc Anaesth 2007;21:847-850.
6. Brienza N, Malcangi V, Dalfino L, et al. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 2006;34:707-714.
7. Ackerman DM, Blumberg AL, McCafferty JP, Sherman SS, Weinstock J, Kaiser C, Berkowitz B. Potential usefulness of renal vasodilators in hypertension and renal disease: SK&F 82526. Fed Proc 1983;42:186-190.
8. Shusterman NH, Elliott WJ, White WB. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med 1993;95:161-168.
9. Singer I, Epstein M. Potential of dopamine A-1 agonist in the management of acute renal failure. Am J of Kidney Dis 1998;31:743-755.
10. Davis GA, Chandler MH. Comparison of creatinine clearance estimation methods in patients with trauma. Am J Health Syst Pharm 1996;53:1028-1032.
11. Mathur VS, Swan SK, Lambrecht LJ, et al. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999;27:1832-1837.
12. Landoni G, Biondi-Zoccai GG, Tumlin JA, et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: A meta-analysis of randomized clinical trials. Am J Kidney Dis 2007;49:56-68.
13. Landoni G, Biondi-Zoccai GG, Marino G, et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: A meta-analysis. J Cardiothorac Vasc Anesth 2008;22:27-33.
14. Morelli A, Rocco M, Conti G, Orecchioni A, Alberto De Blasi R, Coluzzi F, Pietropaoli P. Monitoring renal oxygen supply in critically-ill patients using urinary oxygen tension. Anesth Analg 2003;97:1764-1768.
15. Morelli A, Ricci Z, Bellomo R, et al. Prophylactic fenoldopam for renal protection in sepsis: A randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 2005;33:2451-2456.
16. Bove T, Landoni G, Calabrò MG, et al. Renoprotective action of fenoldopam in high risk patients undergoing cardiac surgery: A prospective, double-blind, randomized clinical trial. Circulation 2005;11:3230-3235.
17. Kellum JA, M Decker J. Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 2001;29:1526-1531.
18. Tumlin JA, Finkel KW, Murray PT, Samuels J, Cotsonis G, Shaw AD. Fenoldopam mesylate in early acute tubular necrosis: A randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 2005;46:26-34.
19. Roasio A, Lobreglio R, Santin A, Landoni G, Verdecchia C. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery. J Cardiothorac Vasc Anesth 2008;22:23-26.